Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Use of B-Cell–Depleting Therapy in Women of Childbearing Potential With Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder
Alexandra Galati, Thomas F. McElrath, Riley Bove
Neurology Clinical Practice (2022) Vol. 12, Iss. 2, pp. 154-163
Open Access | Times Cited: 19

Showing 19 citing articles:

Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management
Tania Kümpfel, Katrin Giglhuber, Orhan Aktaş, et al.
Journal of Neurology (2023) Vol. 271, Iss. 1, pp. 141-176
Open Access | Times Cited: 82
Advances in the long-term treatment of neuromyelitis optica spectrum disorder
Monique Anderson, Michael Levy
Journal of Central Nervous System Disease (2024) Vol. 16
Open Access | Times Cited: 5
New-Onset Neuromyelitis Optica Spectrum Disorder during Pregnancy: A Case Report
S. Lee, Seongheon Kim, Se Jin Lee, et al.
Perinatology (2025) Vol. 36, Iss. 1, pp. 32-32
Open Access
Stiff Person Spectrum Disorders—An Update and Outlook on Clinical, Pathophysiological and Treatment Perspectives
Benjamin Vlad, Yujie Wang, Scott D. Newsome, et al.
Biomedicines (2023) Vol. 11, Iss. 9, pp. 2500-2500
Open Access | Times Cited: 9
Practical Considerations for Managing Pregnancy in Patients With Multiple Sclerosis
Edith L. Graham, Riley Bove, Kathleen Costello, et al.
Neurology Clinical Practice (2024) Vol. 14, Iss. 2
Open Access | Times Cited: 3
Assisted Reproductive Techniques in Multiple Sclerosis: Recommendations from an Expert Panel
Celia Oreja‐Guevara, Aintzane Rabanal, Corazón Hernández Rodríguez, et al.
Neurology and Therapy (2023)
Open Access | Times Cited: 9
Disease Evolution in Women With Highly Active MS Who Suspended Natalizumab During Pregnancy vs Rituximab/Ocrelizumab Before Conception
Sarah Demortière, Adil Maarouf, Audrey Rico, et al.
Neurology Neuroimmunology & Neuroinflammation (2023) Vol. 10, Iss. 5
Open Access | Times Cited: 9
A systematic literature review to examine the considerations around pregnancy in women of child-bearing age with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) or aquaporin 4 neuromyelitis optica spectrum disorder (AQP4+ NMOSD)
Maria Isabel Leite, Zoya Panahloo, Niall Harrison, et al.
Multiple Sclerosis and Related Disorders (2023) Vol. 75, pp. 104760-104760
Closed Access | Times Cited: 8
Pregnancy and Infant Outcomes in Women With Multiple Sclerosis Treated With Ocrelizumab
Sandra Vukusic, Riley Bove, Ruth Dobson, et al.
Neurology Neuroimmunology & Neuroinflammation (2024) Vol. 12, Iss. 1
Closed Access | Times Cited: 1
Neuroimmunological Disorders
Edith L. Graham
Neurologic Clinics (2023) Vol. 41, Iss. 2, pp. 315-330
Closed Access | Times Cited: 2
Monoclonal antibody therapies for aquaporin-4-immunoglobulin G-positive neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease
Nanthaya Tisavipat, Hui Yu Juan, John J. Chen
Saudi Journal of Ophthalmology (2023) Vol. 38, Iss. 1, pp. 2-12
Open Access | Times Cited: 2
Pregnancy and antibody-mediated CNS disorders: What do we know and what should we know?
Rosa Cortese, Sara Mariotto, Chiara Mancinelli, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 3
Multiple sclerosis treatment review for primary care providers
Jeffrey Hernandez
The Nurse Practitioner (2024) Vol. 49, Iss. 7, pp. 38-47
Open Access
Clinical Experience with Dimethyl Fumarate and Natalizumab in Pregnant Women with Multiple Sclerosis: A Four‐Patient Case Series
Satoshi Saito, Ryotaro Ikeguchi, Kazuo Kitagawa, et al.
Case Reports in Neurological Medicine (2024) Vol. 2024, Iss. 1
Open Access
Therapeutic Approach to Autoimmune Neurologic Disorders
Stacey Clardy, Tammy Smith
CONTINUUM Lifelong Learning in Neurology (2024) Vol. 30, Iss. 4, pp. 1226-1258
Closed Access
B-cell Depletion Therapy in Pediatric Neuroinflammatory Disease
Helen C Wu, Grace Gombolay, Jennifer H. Yang, et al.
Current Neurology and Neuroscience Reports (2024) Vol. 24, Iss. 10, pp. 479-494
Closed Access
Fármacos modificadores de la enfermedad en la esclerosis múltiple durante la lactancia: revisión de la evidencia actual
Sara Sánchez-Velasco, Luciana Midaglia, Ángela Vidal‐Jordana, et al.
Revista de Neurología (2023) Vol. 76, Iss. 01, pp. 21-21
Open Access | Times Cited: 1
Monoclonal antibody treatment for multiple sclerosis and neuromyelitis optica spectrum disorder: An update
Yuko Shimizu
Clinical and Experimental Neuroimmunology (2022) Vol. 13, Iss. 3, pp. 131-132
Closed Access | Times Cited: 1
[Pregnancy-associated neuromyelitis optical spectrum disorder combined with primary Sjögren's syndrome: A critical illness case report].
Jie Wu, Wen Zhang, Liang Shu, et al.
PubMed (2023) Vol. 55, Iss. 6, pp. 1118-1124
Closed Access
Page 1

Scroll to top